Dr. Kramer brings more than 25 years of experience in neuroscience and medical affairs leadership across the biopharmaceutical sector. Most recently, he served as Vice President and Head of Medical Neuroscience with Bristol Myers Squibb, where he led integrated medical strategy teams supporting major neuropsychiatry programs. Earlier in his career, he held senior medical affairs leadership roles with Karuna Therapeutics and AbbVie, with deep expertise spanning scientific engagement, evidence generation, and launch readiness in neuroscience.
About Helus Pharma
Helus Pharma is a clinical stage pharmaceutical company committed to helping minds heal through the development of proprietary novel serotonergic agonists (NSAs), designed to address significant unmet needs in mental health. The company is advancing a pipeline of therapies for conditions including major depressive disorder and generalized anxiety disorder, with operations across Canada, the United States, the United Kingdom, and Ireland
